MWC
CRL icon

MBM Wealth Consultants’s Charles River Laboratories CRL Stock Holding History

MBM Wealth Consultants’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,473
Closed -$846K – 219
2018
Q4 		$846K Buy
+7,473
New +$936K 0.82% 30

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

MBM Wealth Consultants's CRL Position: Q1 2019 in Review

MBM Wealth Consultants sold out of Charles River Laboratories (CRL) in Q1 2019, closing a stake of 7,473 shares — an estimated $846K sold.

MBM Wealth Consultants first reported a position in CRL in Q4 2018 and held it in 1 quarter. The position peaked at $846K in Q4 2018. 409 funds tracked by Wall St. Rank hold CRL as of Q1 2019.

  • MBM Wealth Consultants reported no remaining Charles River Laboratories position as of Q1 2019 after selling out during the quarter.
  • MBM Wealth Consultants sold 7,473 Charles River Laboratories shares in Q1 2019, an estimated $846K.
  • MBM Wealth Consultants first reported a position in Charles River Laboratories in Q4 2018 and held it in 1 quarter.
  • MBM Wealth Consultants's Charles River Laboratories position peaked at $846K in Q4 2018.
  • 409 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2019.

Based on MBM Wealth Consultants's 13F filing for Q1 2019, filed 25 Apr 2019.